305 related articles for article (PubMed ID: 15916700)
21. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
Quinn D
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
[TBL] [Abstract][Full Text] [Related]
22. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity.
Schweitzer JB; Lee DO; Hanford RB; Zink CF; Ely TD; Tagamets MA; Hoffman JM; Grafton ST; Kilts CD
Biol Psychiatry; 2004 Oct; 56(8):597-606. PubMed ID: 15476690
[TBL] [Abstract][Full Text] [Related]
23. Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats.
Panos JJ; O'Callaghan JP; Miller DB; Ferguson SA
Neurotoxicol Teratol; 2014; 45():70-4. PubMed ID: 25132048
[TBL] [Abstract][Full Text] [Related]
24. The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome.
Green T; Weinberger R; Diamond A; Berant M; Hirschfeld L; Frisch A; Zarchi O; Weizman A; Gothelf D
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):589-95. PubMed ID: 22149470
[TBL] [Abstract][Full Text] [Related]
25. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
[TBL] [Abstract][Full Text] [Related]
26. Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies.
Britton GB
Int J Neuropsychopharmacol; 2012 Feb; 15(1):41-53. PubMed ID: 21439107
[TBL] [Abstract][Full Text] [Related]
27. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
[TBL] [Abstract][Full Text] [Related]
29. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
[TBL] [Abstract][Full Text] [Related]
30. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
31. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
32. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
33. Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants.
Schmeichel BE; Berridge CW
Neuropsychopharmacology; 2013 May; 38(6):1078-84. PubMed ID: 23303075
[TBL] [Abstract][Full Text] [Related]
34. Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats.
Bethancourt JA; Camarena ZZ; Britton GB
Behav Brain Res; 2009 Aug; 202(1):50-7. PubMed ID: 19447280
[TBL] [Abstract][Full Text] [Related]
35. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
Teicher MH; Polcari A; Foley M; Valente E; McGreenery CE; Chang WW; McKay G; Midha KK
J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):416-31. PubMed ID: 16958567
[TBL] [Abstract][Full Text] [Related]
36. Blockade of adenosine A(1) receptors prevents methylphenidate-induced impairment of object recognition task in adult mice.
Mioranzza S; Costa MS; Botton PH; Ardais AP; Matte VL; Espinosa J; Souza DO; Porciúncula LO
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):169-76. PubMed ID: 21044657
[TBL] [Abstract][Full Text] [Related]
37. Dopamine transporter genotype influences the physiological response to medication in ADHD.
Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial.
Yang L; Cao Q; Shuai L; Li H; Chan RC; Wang Y
Int J Neuropsychopharmacol; 2012 Feb; 15(1):15-26. PubMed ID: 22017969
[TBL] [Abstract][Full Text] [Related]
39. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
[TBL] [Abstract][Full Text] [Related]
40. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
